Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Kala Bio Inc
(NQ:
KALA
)
7.007
+0.252 (+3.74%)
Streaming Delayed Price
Updated: 3:37 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kala Bio Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
KALA Stock Earnings: Kala Pharmaceuticals Beats EPS for Q4 2023
April 02, 2024
KALA stock results show that Kala Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 29, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
February 26, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
Kala Bio: Q3 Earnings Insights
November 13, 2023
Via
Benzinga
Kala Pharmaceuticals: Q1 Earnings Insights
May 09, 2023
Kala Pharmaceuticals (NASDAQ:KALA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 05, 2023
Via
Benzinga
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 20, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
Where Kala Pharmaceuticals Stands With Analysts
May 01, 2023
Via
Benzinga
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 04, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Participate in Upcoming Investor Conferences in August
August 02, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
Kala Pharmaceuticals Announces Name Change to KALA BIO
August 02, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
10 Short Squeeze Stocks To Watch: Aeglea Biotherapeutics, Toro Corp, AirSculpt, A Company Moves Up 4,166 Positions & More
July 24, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 19, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 23, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
June 02, 2023
Via
Benzinga
Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
10 Short Squeeze Stocks To Watch: Toro Corp, PaxMedica, Getty Images And More
May 15, 2023
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High-short interest and high-cost to borrow are among the...
Via
Benzinga
Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 09, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
5 Short Squeeze Stocks To Watch: Getty Images, Bullfrog AI And A New Leader For The Week
May 08, 2023
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the...
Via
Benzinga
Combangio, Inc., a Wholly Owned Subsidiary of Kala Pharmaceuticals, Awarded $15 Million by California Institute for Regenerative Medicine to Support Ongoing KPI-012 Program for the Treatment of PCED
April 28, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
10 Short Squeeze Stocks To Watch: Getty Images, Guardforce AI And 2 Stocks Moving Up Over 1,000 Positions On The Leaderboard
April 24, 2023
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the...
Via
Benzinga
5 Short Squeeze Stocks To Watch: Getty Images, PaxMedica, A Mental Health Care Company And More
April 17, 2023
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the...
Via
Benzinga
Kala Pharmaceuticals Receives FDA Fast Track Designation for KPI-012, a Human MSC-S Therapy for Persistent Corneal Epithelial Defect
April 12, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Short Interest Sector Focus: Healthcare Sector
April 04, 2023
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More
April 03, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...
Via
Benzinga
Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor
March 29, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.